trending Market Intelligence /marketintelligence/en/news-insights/trending/A6WuRUVKjU86sRGDCAOsjA2 content esgSubNav
In This List

Tvardi Therapeutics names CEO

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


Tvardi Therapeutics names CEO

Tvardi Therapeutics Inc. said it appointed Imran Alibhai as the company's CEO and board member, effective immediately.

Previously, Alibhai served as senior vice president and managing director at DNAtrix Inc. He was also an investment banker in PJ Solomon LP's healthcare advisory group. In addition, he held investing roles at Accelerator Corp., Alexandria Venture Investments LLC and MPM Capital.

Houston-based Tvardi Therapeutics is a biotechnology company that develops medicines for the treatment of cancer, chronic inflammation and fibrosis.